Scholar Rock Holding SRRK Stock
Scholar Rock Holding Price Chart
Scholar Rock Holding SRRK Financial and Trading Overview
| Scholar Rock Holding stock price | 45.67 USD |
| Previous Close | 8.54 USD |
| Open | 8.46 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 7.96 - 8.64 USD |
| 52 Week Range | 4.44 - 13 USD |
| Volume | 243.48K USD |
| Avg. Volume | 236.04K USD |
| Market Cap | 459.85M USD |
| Beta (5Y Monthly) | 0.76338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.14 USD |
SRRK Valuation Measures
| Enterprise Value | 252.06M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.78125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 1.9258755 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.546 |
Trading Information
Scholar Rock Holding Stock Price History
| Beta (5Y Monthly) | 0.76338 |
| 52-Week Change | 57.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13 USD |
| 52 Week Low | 4.44 USD |
| 50-Day Moving Average | 7.39 USD |
| 200-Day Moving Average | 8.56 USD |
SRRK Share Statistics
| Avg. Volume (3 month) | 236.04K USD |
| Avg. Daily Volume (10-Days) | 222.83K USD |
| Shares Outstanding | 54.29M |
| Float | 32.68M |
| Short Ratio | 16.07 |
| % Held by Insiders | 3.21% |
| % Held by Institutions | 99.93% |
| Shares Short | 4.05M |
| Short % of Float | 22.00% |
| Short % of Shares Outstanding | 7.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.74% |
| Return on Equity (ttm) | -82.97% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -89851000 USD |
| EBITDA | -163076000 USD |
| Net Income Avi to Common (ttm) | -165931008 USD |
| Diluted EPS (ttm) | -2.99 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 275.28M USD |
| Total Cash Per Share (mrq) | 5.07 USD |
| Total Debt (mrq) | 67.5M USD |
| Total Debt/Equity (mrq) | 29.52 USD |
| Current Ratio (mrq) | 10.957 |
| Book Value Per Share (mrq) | 4.398 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -133183000 USD |
| Levered Free Cash Flow (ttm) | -67912752 USD |
Profile of Scholar Rock Holding
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 301 Binney Street |
| ZIP | 02142 |
| Phone | 857 259 3860 |
| Website | https://scholarrock.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 114 |
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and iron-restricted anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Q&A For Scholar Rock Holding Stock
What is a current SRRK stock price?
Scholar Rock Holding SRRK stock price today per share is 45.67 USD.
How to purchase Scholar Rock Holding stock?
You can buy SRRK shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scholar Rock Holding?
The stock symbol or ticker of Scholar Rock Holding is SRRK.
Which industry does the Scholar Rock Holding company belong to?
The Scholar Rock Holding industry is Biotechnology.
How many shares does Scholar Rock Holding have in circulation?
The max supply of Scholar Rock Holding shares is 102.01M.
What is Scholar Rock Holding Price to Earnings Ratio (PE Ratio)?
Scholar Rock Holding PE Ratio is now.
What was Scholar Rock Holding earnings per share over the trailing 12 months (TTM)?
Scholar Rock Holding EPS is -3.15 USD over the trailing 12 months.
Which sector does the Scholar Rock Holding company belong to?
The Scholar Rock Holding sector is Healthcare.
Scholar Rock Holding SRRK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23593.1 USD — |
-0.09
|
4.43B USD — | 23567.86 USD — | 23665.15 USD — | — - | 4.43B USD — |
| US Tech Global Select Market Com NQGS | 11560.74 USD — |
-0.05
|
— — | 11548.2 USD — | 11595.66 USD — | — - | — — |
| US Tech Biotechnology NBI | 5809.25 USD — |
-0.59
|
— — | 5792.54 USD — | 5835.34 USD — | — - | — — |
| US Tech Health Care IXHC | 1206.13 USD — |
-0.49
|
— — | 1203.49 USD — | 1210.54 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}